Skip to main content
. 2022 Apr 7;13:801056. doi: 10.3389/fgene.2022.801056

TABLE 1.

The clinical characteristics of BC patients from the TCGA and GEO databases.

Characteristics Detailed data IGGC cohort (n = 107)
TCGA cohort (n = 1076) GEO cohort (n = 327)
Status Dead 150 (13.94) 103 (25.38) 4 (3.74)
Survival 926 (86.06) 244 (74.62) 103 (96.26)
Age at diagnosis (years) ≤65 773 (71.84) 305 (93.27) 85 (79.44)
>65 303 (28.16) 22 (6.73) 22 (20.56)
Gender Female 1064 (98.88) 327 (100) 107 (100)
Male 12 (1.12)
Stage 1 183 (17.01)
2 608 (56.51)
3 242 (22.49)
4 24 (2.23)
NA 23 (1.76)
T T0 3 (2.80)
T1 281 (26.12) 101 (30.89) 34 (31.78)
T2 621 (57.71) 188 (57.49) 59 (55.14)
T3 133 (12.36) 26 (7.95) 6 (5.61)
T4 38 (3.53) 12 (3.67) 1 (0.93)
NA 3 (0.28) 4 (3.74)
M M0 895 (83.18) 319 (97.55) 103 (96.26)
M1 22 (2.04) 8 (2.45)
NA 159 (14.78) 4 (3.74)
N N0 504 (46.84) 137 (41.90) 50 (46.73)
N1 361 (33.55) 87 (26.61) 37 (34.58)
N2 120 (11.15) 63 (19.27) 11 (10.28)
N3 74 (6.88) 40 (12.22) 5 (4.67)
NA 17 (1.58) 4 (3.74)

NA, not available.